OR WAIT null SECS
October 30, 2015.
Valeant Pharmaceuticals International has announced that it is severing all ties with Philidor Rx Services, LLC.
Valeant boss J. Michael Pearson explained: "The newest allegations about activities at Philidor raise additional questions about the company's business practices. We have lost confidence in Philidor's ability to continue to operate in a manner that is acceptable to Valeant and the patients and doctors we serve."
Valeant reports that it intends to develop a plan to ensure patients' access to drugs is minimally disrupted. The company has informed Philidor that to the extent that managed care plans will no longer reimburse prescriptions in process, Valeant will fill them at the company's expense.
"We are committed to doing everything we can to provide important medicines to the patients and doctors who depend on them, and will continue to explore relationships with the full range of pharmacies to ensure patients have access to the drugs they need," Pearson added.